TrialChest2008

Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).

Alexandra Papaioannou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.